← Back to Search

Procedure

Wavefront optimized Photorefractive Keratectomy for Near-sightedness

N/A
Waitlist Available
Led By Mark Mifflin, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will compare the results of two different types of laser vision correction surgeries.

Eligible Conditions
  • Near-sightedness
  • Surgery

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Uncorrected Visual Acuity From Baseline to Month 12
Secondary outcome measures
Change in Contrast Sensitivity From Baseline to Month 3
Other outcome measures
Change in Quality of Life Score From Baseline to 3 Months

Trial Design

4Treatment groups
Active Control
Group I: Wavefront optimized Photorefractive KeratectomyActive Control2 Interventions
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Wavefront optimized Photorefractive Keratectomy in one eye and Topography-guided Photorefractive Keratectomy in the other eye (randomly chosen).
Group II: Topography-guided LASIKActive Control2 Interventions
Participants who chose to have LASIK surgery were assigned to have Topography-guided LASIK in one eye and Wavefront optimized LASIK in the other eye (randomly chosen).
Group III: Wavefront optimized LASIKActive Control2 Interventions
Participants who chose to have LASIK surgery were assigned to have Wavefront optimized LASIK in one eye and Topography-guided LASIK in the other eye (randomly chosen).
Group IV: Topography-guided Photorefractive KeratectomyActive Control2 Interventions
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Topography-guided Photorefractive Keratectomy in one eye and Wavefront optimized Photorefractive Keratectomy in the other eye (randomly chosen).

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,650 Total Patients Enrolled
Mark Mifflin, MDPrincipal Investigator - University of Utah Moran Eye Center
LDS Hospital, Primary Children's Hospital, University of Utah Hospital
University Of Nevada School Of Medicine (Medical School)
University Of Ut Medical Center (Residency)
2 Previous Clinical Trials
175 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025